Emami Valuation

Is 531162 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 531162 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 531162 (₹635) is trading above our estimate of fair value (₹301.92)

Significantly Below Fair Value: 531162 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 531162?

Key metric: As 531162 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 531162. This is calculated by dividing 531162's market cap by their current earnings.
What is 531162's PE Ratio?
PE Ratio35.9x
Earnings₹7.73b
Market Cap₹281.26b

Price to Earnings Ratio vs Peers

How does 531162's PE Ratio compare to its peers?

The above table shows the PE ratio for 531162 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average72.8x
507815 Gillette India
66.2xn/a₹302.6b
500459 Procter & Gamble Hygiene and Health Care
76.2x15.9%₹513.0b
500830 Colgate-Palmolive (India)
49.8x9.6%₹742.7b
HONASA Honasa Consumer
98.9x43.7%₹85.8b
531162 Emami
35.9x11.4%₹281.3b

Price-To-Earnings vs Peers: 531162 is good value based on its Price-To-Earnings Ratio (35.9x) compared to the peer average (72.8x).


Price to Earnings Ratio vs Industry

How does 531162's PE Ratio compare vs other companies in the IN Personal Products Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
531162 35.9xIndustry Avg. 25.2xNo. of Companies2PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 531162 is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the Asian Personal Products industry average (25.2x).


Price to Earnings Ratio vs Fair Ratio

What is 531162's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

531162 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio35.9x
Fair PE Ratio43.9x

Price-To-Earnings vs Fair Ratio: 531162 is good value based on its Price-To-Earnings Ratio (35.9x) compared to the estimated Fair Price-To-Earnings Ratio (43.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 531162 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹635.00
₹801.12
+26.2%
14.9%₹980.00₹510.00n/a26
Nov ’25₹716.80
₹867.62
+21.0%
14.1%₹1,025.00₹510.00n/a26
Oct ’25₹748.75
₹867.81
+15.9%
14.1%₹1,025.00₹510.00n/a26
Sep ’25₹813.25
₹867.96
+6.7%
14.1%₹1,025.00₹510.00n/a26
Aug ’25₹823.10
₹755.40
-8.2%
18.3%₹1,025.00₹510.00n/a25
Jul ’25₹722.05
₹650.81
-9.9%
13.2%₹816.00₹510.00n/a26
Jun ’25₹624.15
₹617.59
-1.1%
7.7%₹735.00₹510.00n/a27
May ’25₹486.60
₹563.89
+15.9%
7.8%₹630.00₹470.00n/a27
Apr ’25₹439.90
₹572.59
+30.2%
7.4%₹650.00₹500.00n/a27
Mar ’25₹455.35
₹572.59
+25.7%
7.4%₹650.00₹500.00n/a27
Feb ’25₹497.00
₹593.08
+19.3%
9.2%₹690.00₹480.00n/a26
Jan ’25₹573.35
₹583.96
+1.9%
8.3%₹665.00₹480.00n/a26
Dec ’24₹514.60
₹582.00
+13.1%
8.2%₹665.00₹480.00n/a26
Nov ’24₹511.75
₹561.16
+9.7%
10.3%₹660.00₹450.00₹716.8025
Oct ’24₹537.85
₹547.63
+1.8%
10.2%₹660.00₹450.00₹748.7524
Sep ’24₹535.45
₹532.74
-0.5%
9.7%₹660.00₹450.00₹813.2523
Aug ’24₹462.25
₹480.96
+4.0%
8.8%₹590.00₹410.00₹823.1023
Jul ’24₹424.25
₹479.68
+13.1%
9.1%₹590.00₹410.00₹722.0522
Jun ’24₹387.40
₹482.52
+24.6%
9.7%₹590.00₹410.00₹624.1523
May ’24₹375.00
₹493.50
+31.6%
11.8%₹660.00₹410.00₹486.6022
Apr ’24₹358.40
₹501.19
+39.8%
11.2%₹660.00₹419.00₹439.9021
Mar ’24₹395.30
₹508.26
+28.6%
11.1%₹660.00₹419.00₹455.3523
Feb ’24₹427.65
₹549.61
+28.5%
8.7%₹660.00₹470.00₹497.0023
Jan ’24₹425.20
₹559.67
+31.6%
7.6%₹660.00₹470.00₹573.3524
Dec ’23₹463.40
₹559.67
+20.8%
7.6%₹660.00₹470.00₹514.6024
Nov ’23₹484.75
₹562.13
+16.0%
9.3%₹668.00₹470.00₹511.7524

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies